Larvol Delta - Akiram-Therapeutics-Cohort-2a-completed-and-cohort-2b-cleared-to-start-in-Phase-I-trial-of-AKIR001

AKIR001 - Akiram Therapeutics

https://news.cision.com/akiram-therapeutics/r/akiram-therapeutics--cohort-2a-completed-and-cohort-2b-cleared-to-start-in-phase-i-trial-of-akir001,c4282290

Dec 16, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev